These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20737517)

  • 1. Relative association of treatment-emergent adverse events with quality of life of patients with schizophrenia: post hoc analysis from a 3-year observational study.
    Adrianzén C; Arango-Dávila C; Araujo DM; Ruíz I; Walton RJ; Dossenbach M; Karagianis J
    Hum Psychopharmacol; 2010 Aug; 25(6):439-47. PubMed ID: 20737517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia.
    Bebbington PE; Angermeyer M; Azorin JM; Marwaha S; Marteau F; Toumi M
    Acta Psychiatr Scand Suppl; 2009; (438):22-8. PubMed ID: 19132963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The change of quality of life and clinical picture in schizophrenia].
    Jarema M; Konieczyńska Z; Murawiec S; Szafrański T; Szaniawska A
    Psychiatr Pol; 2002; 36(3):393-402. PubMed ID: 12149915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs and the quality of life: the patient's point of view.
    Diamond R
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):29-35. PubMed ID: 2859278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
    Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
    Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: a 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
    Ritsner MS; Yorkov V; Ratner Y; Soifer P; Gibel A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1470-7. PubMed ID: 17669573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course of adherence to medication and quality of life in people with schizophrenia.
    Puschner B; Angermeyer MC; Leese M; Thornicroft G; Schene A; Kikkert M; Burti L; Tansella M; Becker T
    Psychiatry Res; 2009 Feb; 165(3):224-33. PubMed ID: 19155070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
    Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
    J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching to long-acting injectable risperidone is beneficial with regard to clinical outcomes, regardless of previous conventional medication in patients with schizophrenia.
    Marinis TD; Saleem PT; Glue P; Arnoldussen WJ; Teijeiro R; Lex A; Latif MA; Medori R
    Pharmacopsychiatry; 2007 Nov; 40(6):257-63. PubMed ID: 18030649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
    Hornung WP; Schonauer K; Feldmann R; Mönking HS
    Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia.
    Canuso CM; Bossie CA; Amatniek J; Turkoz I; Pandina G; Cornblatt B
    Early Interv Psychiatry; 2010 Feb; 4(1):64-78. PubMed ID: 20199482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What information do patients with schizophrenia have about their illness and treatment?].
    Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
    Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication.
    Rofail D; Heelis R; Gournay K
    Clin Ther; 2009 Jun; 31 Pt 1():1488-96. PubMed ID: 19698906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.